| scholarly article | Q13442814 |
| P2093 | author name string | Saverio Cinti | |
| Giuseppe Pugliese | |||
| Stefano Menini | |||
| Martina Vitale | |||
| Andrea Giaccari | |||
| Carla Iacobini | |||
| Claudia Blasetti Fantauzzi | |||
| Teresa Mezza | |||
| Gian Pio Sorice | |||
| P2860 | cites work | Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues | Q26753066 |
| Role of Galectin-3 in Obesity and Impaired Glucose Homeostasis | Q26771826 | ||
| Galectin-3 is a new MerTK-specific eat-me signal | Q33972695 | ||
| Effect of 8 weeks of overfeeding on ectopic fat deposition and insulin sensitivity: testing the "adipose tissue expandability" hypothesis | Q34219418 | ||
| Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals | Q34448725 | ||
| Inflammation, metaflammation and immunometabolic disorders | Q34550852 | ||
| Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice | Q34603941 | ||
| Subcutaneous adipose cell size and distribution: relationship to insulin resistance and body fat | Q35130591 | ||
| Critical role of galectin-3 in phagocytosis by macrophages | Q35169042 | ||
| Role of galectin-3 in diabetic nephropathy | Q35182376 | ||
| Abdominal obesity: a marker of ectopic fat accumulation | Q35720154 | ||
| Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes | Q35842591 | ||
| Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis. | Q37076498 | ||
| Interleukin-6 and insulin resistance | Q37403996 | ||
| Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism | Q37413810 | ||
| What we talk about when we talk about fat. | Q37601812 | ||
| Adiposopathy is "sick fat" a cardiovascular disease? | Q37890583 | ||
| Adipogenesis: from stem cell to adipocyte | Q37998565 | ||
| Ectopic fat and cardiometabolic and vascular risk. | Q38142395 | ||
| Galectin-3: an emerging all-out player in metabolic disorders and their complications | Q38258947 | ||
| Adipose tissue-specific modulation of galectin expression in lean and obese mice: evidence for regulatory function | Q38317758 | ||
| Expression of interleukin-6 is greater in preadipocytes than in adipocytes of 3T3-L1 cells and C57BL/6J and ob/ob mice | Q38335831 | ||
| Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus | Q39197051 | ||
| Inflammation in subcutaneous adipose tissue: relationship to adipose cell size. | Q39940257 | ||
| Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets | Q40944709 | ||
| Time course of histomorphological changes in adipose tissue upon acute lipoatrophy | Q42042214 | ||
| Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle | Q42135596 | ||
| Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance. | Q42805774 | ||
| Galectin-3 activates PPARγ and supports white adipose tissue formation and high-fat diet-induced obesity. | Q42834230 | ||
| Lower total adipocyte number but no evidence for small adipocyte depletion in patients with type 2 diabetes | Q43143653 | ||
| Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver. | Q45052723 | ||
| How obesity causes diabetes: not a tall tale | Q45232061 | ||
| FL-926-16, a novel bioavailable carnosinase-resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy in db/db mice | Q46279581 | ||
| Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia. | Q51570788 | ||
| The advanced glycation end-product Nϵ -carboxymethyllysine promotes progression of pancreatic cancer: implications for diabetes-associated risk and its prevention. | Q51740842 | ||
| Galectin-3 stimulates preadipocyte proliferation and is up-regulated in growing adipose tissue. | Q53576992 | ||
| Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes | Q80010792 | ||
| Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis | Q80430041 | ||
| Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management | Q88182023 | ||
| Adipose Organ Development and Remodeling | Q91446295 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 20070 | |
| P577 | publication date | 2020-11-18 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Galectin-3 gene deletion results in defective adipose tissue maturation and impaired insulin sensitivity and glucose homeostasis | |
| P478 | volume | 10 |
Search more.